Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review
Hepatocellular carcinoma (HCC) is a rapidly rising global health concern, ranking as the third-leading cause of cancer-related mortality. Despite medical advancements, the five-year survival rate remains a dismal 18%, with a daunting 70% recurrence rate within a five-year period. Current systematic...
Main Authors: | Xiaokun Chen, Xiao Liu, Shunda Du |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/20/5046 |
Similar Items
-
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
by: Carmelo Laface, et al.
Published: (2023-01-01) -
Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
by: Keyur Patel, et al.
Published: (2020-09-01) -
The Tumor Microenvironment of Hepatocellular Carcinoma: Untying an Intricate Immunological Network
by: Camilla Volponi, et al.
Published: (2022-12-01) -
Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma
by: Li Z, et al.
Published: (2023-11-01) -
The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
by: Stavros P. Papadakos, et al.
Published: (2023-05-01)